Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
NCT03015129, 2023 | randomized controlled trial | phase 2 study |
Rubinstein MM Gynecol Oncol 2023; 169:64-69-. 10.1016/j.ygyno.2022.11.028 |
||
Konstantinopoulos, 2022 | single-arm |